User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 3 results.
    • Speech
    Sunitinib plus docetaxel and trastuzumab as first-line therapy for HER2+advanced breast cancer
    Cardoso, F. Canon, J. L. Amadori, D. Dirix, L. Villa, E. Aldrighetti, D. Machiels, Jean-Pascal[UCL] Verkh, L. Kern, K. Giorgetti, C. (2009) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology — Berlin(Germany)
    • Speech
    An Exploratory Study of Sunitinib (SU) Plus Docetaxel (D) and Trastuzumab (T) for First-Line Therapy of HER2+Advanced Breast Cancer (ABC).
    Dirix, L. Machiels, Jean-Pascal[UCL] Canon, Jean-Luc Amadori, D. Villa, E. Aldrighetti, D. Verkh, L. Bouko, Y. Kem, K. Giorgetti, C. Cardoso, F. (2009) 32nd Annual San Antonio Breast Cancer Symposium — (United-States) San Antonio, Texas
    • Speech
    Tolerability of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2+advanced breast cancer : Abstract #4120
    Cardoso, F. Canon, J-L. Amadori, D. Dirix, L. Villa, E. Aldrighetti, D. Machiels, Jean-Pascal[UCL] Verkh, L. Huang, X. Giorgetti, C. (2009) 31st Annual San Antonio Breast Cancer Symposium — (USA) San Antonio, Texas